hypercholesterolemia. Excellent safety profile, cost effectiveness and multiple beneficial effects aimed at improving the total quality of life of man, all contribute to the emerging trend of the increasing usage of dietary or herbal supplement around the world. 8 Previous researchers have demonstrated that some plant chemicals regarded as anti-nutrients have the potential to reduce the risk of several deadly diseases in man. 9 Further reports show that these phytochemicals reduce LDL-cholesterol involved in depositing fat in the arteries, prevent blood clotting which can reduce the risk of heart attack or stroke. 10 A great number of traditional medicinal plants are still being used to treat diabetes and cardiovascular disease.
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G. latifolium is edible plant widely consumed in south eastern Nigeria. The south-eastern inhabitants of Nigeria are known for their high consumption of vegetables and some of these vegetables form part of foods consumed on special conditions, including ill health and times of convalescence. 12 This stresses the role of plants in the life of man from past till date. As an old companion of man, it has provided food, shelter, wealth and has helped to maintain a relatively disease free state when properly utilized as herbal medicine. 5 Although, modern medicine may be available in developing countries but the use of herbs for treatment of diseases has often maintained popularity for historical and cultural reasons. 13 There have been speculations that these plant products after consumption have effect on blood glucose and lipid profile but there is no scientific evidence documented for human model. The incidence of diseases associated with hypercholesterolemia and hyperglycemia are on the increase in Nigerian population and the economic status of most of the affected individuals pose great hindrance in procuring the effective but expensive drugs. However, adverse effects associated with these therapeutic drugs 14 call for the evaluation of other alternative sources for managing these diseases. In recent times, food supplements have increasingly become attractive alternatives to prevent or treat various types of diseases 15 and the current shift away from the use of synthetic chemicals in food processing necessitate a further evaluation of this widely available but underutilized tropical medicinal plants. 16 This research work is therefore aimed at exploring the potential effects of Gongronema latifolium (Utazi) on blood glucose and lipid profile in human subjects.
METHODS

Subjects
A total of twenty (20) apparently healthy subjects (10 males and 10 females) who are staff of Nnamdi Azikiwe University teaching hospital and medical students in Nnewi campus within the age range of 20-55 years were randomly recruited for the study. They were neither diabetic nor hypertensive nor on any medication at the time of the study. The subjects were permitted to continue on their normal diet during the study.
Collection and preparation of G. latifolium leaves
Fresh leaves of G. latifolium were plucked from the farm in Nnewichi village of Nnewi town and a sample was authenticated by a certified Botanist in Nnamdi Azikiwe University, Awka. The leaves were washed and allowed to drain completely, 5 g/day was weighed and served to each subject. In an attempt to maximize its medicinal value and to minimize delayed absorption, each subject consumed their portion of the leaves raw between 8am and 10am (before breakfast) each day for a period of six weeks. It was believed that six weeks would be enough for the leaves to exert its full medicinal effect on the subjects. 
Sample collection
Initial baseline collection of 6 ml of fasting Blood samples were obtained from all the participants between 8am and 10am before the consumption of G. latifolium leaves and dispensed into fluoride oxalate containers (2 ml) and EDTA containers (4 ml). Following consumption of the G. latifolium leaves, fasting blood samples were similarly collected from the subjects between 8am and 10am on Monday of every week till the end of the six weeks period. The plasma and serum samples were respectively used for glucose estimation and total cholesterol, Triglycerides, High Density lipoprotein cholesterol (HDL-C) and Low Density Lipoprotein cholesterol (LDL-C) measurements.
Analytical procedures
All the parameters were analyzed using colorimetric assay kits from Randox Laboratories LTD. United Kingdom. 
Statistical method of analysis
Results of parameters analyzed were expressed as mean ± SD. The mean differences were assessed using Analysis of variance and Paired Student-t test and Post hoc. The data were analyzed using Statistical Package for Social Sciences (SPSS) Version 19. Confidence limit was chosen at 95% (P <0.05). P <0.05 = significant while P >0.05 = Insignificant.
RESULTS
Plasma glucose, total cholesterol, LDL-C/HDL-C of the subjects that consumed G. latifolium were significantly reduced at week four, five and six compared with the baseline, all at P <0.05. The baseline value of triglyceride declined significantly after six weeks of G. latifolium consumption, (P<0.05).
Significant decrease was observed with the mean blood glucose value at weeks three, four five and six (P <0.05) compared with the mean baseline blood glucose. Similarly, the mean plasma cholesterol at weeks four, five and six were significantly reduced compared with the baseline plasma cholesterol value (P <0.05). The mean plasma triglyceride showed a significant reduction at week six (P <0.05). The mean plasma LDL-C value reduced significantly from weeks five and six compared with baseline plasma LDL-C value (P <0.05). The mean plasma LDL-C/HDL-C ratio significantly reduced from weeks four, five and six compared with the baseline value (P <0.05) ( Table 1) . The finding of reduced plasma glucose and lipid parameters recorded in the subjects suggest that G. latifolium leaves may possess hypoglycemic and hypolipidemic properties and this is consistent with previous studies that reported that aqueous and ethanolic G. latifolium extracts had hypoglycemic, hypolipidemic and antioxidative properties in animal model. 17 This observed hypoglycemic potency of G. latifolium has been suggested to be mediated through the activation of hexokinase, phosphofructokinase, glucose-6-phosphate dehydrogenase and inhibition of glucokinase in the liver. 18 When these enzymes are activated, glycolysis and glycogenesis proceed faster resulting in lowering of blood glucose.
Several authors have shown that Gongronema latifolium leaves contain essential oils, fibers, phytochemicals (Saponins, alkaloids, flavonoids, phenols and glycosides) and pregnanes among others. 3, [18] [19] [20] [21] Essential oils are important constituents of some higher plants and have been recognized to possess antimicrobial activities, 22 and phytochemicals are natural plant based chemicals that have been identified as active compounds in the prevention of degenerative diseases like diabetes mellitus and hypertension.
In this study, the plant significantly reduced the cholesterol, triglyceride, LDL-C level and LDL-C levels and LDL-C/HDL-C ratio. The decrease in serum triacylglycerol coupled with an increase in HDL-C suggests that G. latifolium based diet may offer protection to cardiovascular risk. The reduction in LDL-C level observed is consistent with the work of previous researchers 23 which showed that phytochemicals reduce LDL-C involved in depositing fat in the arteries, prevent blood clotting which can reduce the risk of heart attack or stroke.
The ratio of LDL-C to HDL-C referred to as atherogenic index has also been used as indicator of cardiovascular diseases. 24 Therefore, the decrease in the computed atherogenic index of the subjects fed with G. latifolium will reduce the risk of cardiovascular disease.
There was a trend towards increased level of HDL-C in the subjects that were fed with G. latifolium; it is possible that this trend may become significant if the period of feeding is further increased. In this regard, it may protect against cardiovascular risk. Previous researcher 25 reported that HDL-C constitutes a protective factor against cardiovascular diseases. It is essential in the transport of cholesterol from cells and arteries to the liver where it is catabolized 26 and is also considered to have anti-atherogenic properties given that there is a negative correlation between HDL-C and risk of cardiovascular disease. Thus, the hypoglycemic and hypolipidemic effects of G. latifolium could be beneficial in preventing diabetes and cardiovascular disease.
There are few limitations to this study. First, the study subjects were not restricted from eating other plant leaves during the study. Other plant leaves might also have latent hypoglycaemic or hypolipidaemic properties yet undiscovered. Secondly, there were no control subjects (those that did not consume the G. latifolium leaves) to compare their glucose and lipid parameters with the experimental group. Nevertheless, the present study is a preliminary study that warrants further investigation in a case-control study design.
Therefore, we conclude that since the consumption of G. latifolium leaves reduced plasma glucose, cholesterol, triglyceride, LDL-C levels and LDL-C/HDL-C ratio, it may be of benefit in the control and management of diabetes mellitus, and subsequently prevention of coronary heart disease and their associated complications if the leaves are routinely included in the subjects' diets/foods.
